Daniel Aghion - 31 Dec 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role: Director
Signature: /s/ Daniel Aghion
Issuer symbol: ORMP
Transactions as of: 31 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Jan 2026, 20:02:47 UTC
Previous filing: 09 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Aghion Daniel	Director	1185 AVENUE OF THE AMERICAS, NEW YORK	/s/ Daniel Aghion	02 Jan 2026	0002004805

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ORMP	Common Stock	Award		+30,000	+39%		107,191	31 Dec 2025	Direct	F1
transaction	ORMP	Common Stock	Award		+6,250	+5.8%		113,441	31 Dec 2025	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents Restricted Stock Units ("RSUs"). The RSUs will vest ratably in three annual tranches beginning January 1, 2027. Each RSU represents the right to receive one share of common stock, par value $0.012 per share ("Common Stock"), of the Issuer.
F2	Represents RSUs. The RSUs will vest in quarterly installments over a one-year period starting April 1, 2026. Each RSU represents the right to receive one share of Common Stock of the Issuer.